Skip to main content

Table 3 Baseline characteristics of patients with NIV intolerance prior to treatment

From: Remifentanil vs. dexmedetomidine for cardiac surgery patients with noninvasive ventilation intolerance: a multicenter randomized controlled trial

Variables

Total (n = 179)

REM group (n = 89)

DEX group (n = 90)

p value

Reasons for NIV

0.097

 Cardiogenic, n (%)

99 (55.31)

55 (61.80)

44 (49.44)

 

 Noncardiogenic, n (%)

79 (44.13)

34 (38.20)

45 (50.56)

 

Duration from ICU admission to NIV (h)

58.7 (37.5, 115.0)

61.0 (38.0, 128.0)

52.3 (36.0, 93.0)

0.369

NIV parameters

 Vt, ml

525 (480, 574)

523 (483, 567)

531 (475, 578)

0.502

 PS, cmH2O

12 (10, 12)

12 (10, 12)

12 (10, 12)

0.724

 PEEP, cmH2O

5 (5, 6)

5 (5, 6)

5 (5, 6)

0.695

 FiO2, %

60 (50, 70)

60 (50, 70)

60 (50, 80)

0.127

VAS, points

3 (2, 3)

3 (2, 3)

3 (2, 3)

0.992

NIS, points

3 (3, 3)

3 (3, 3)

3 (3, 3)

0.180

Vital signs

 Temperature, °C

37 (36.8, 37.7)

37.2 (36.9, 37.8)

37 (36.7, 37.5)

0.024

 RR, breaths/min

27 ± 9

26 ± 5

28 ± 11

0.515

 HR, bpm

93 (83,105)

93 (83, 104)

91 (81,105)

0.523

 SBP, mmHg

125 (114,141)

125 (113,140)

125 (116,145)

0.536

 DBP, mmHg

63 ± 11

63 ± 11

63 ± 11

0.842

 MAP, mmHg

82 (75, 90)

81(75, 90)

83(76, 90)

0.577

 SpO2, %

98 (96, 100)

98 (96, 99)

98 (96, 100)

0.425

CVP, mmHg

12(10, 14)

12 (10, 14)

12 (11, 14)

0.831

PaO2, mmHg

94.5(74.50,140.85)

94.05(76.75,140.95)

95.3(72.70,139.75)

0.824

PaCO2, mmHg

38.3(34.10,43.75)

38.45(34.55,43.30)

37.85(34.05,44.20)

0.929

Laboratory test

 Hb, g/L

90 (82.00, 101.00)

90 (81.50, 99.00)

90 (83.00, 103.00)

0.655

 WBC, *109/L

11.47 (8.34, 14.03)

10.84 (8.39, 13.31)

11.94 (8.34, 14.64)

0.302

 PLT, *109/L

104 (75, 154)

103.5 (69, 150)

106 (83, 157)

0.180

 ALT, U/L

20 (12.00, 36.50)

21.5 (13.50, 46.50)

19 (12.00, 30.50)

0.206

 AST, U/L

37 (24.50, 61.00)

42 (25.50, 62.00)

34 (23.50, 59.00)

0.210

 TBIL, μmol/L

19.7 (12.80, 30.00)

21.25 (14.30, 30.30)

18.95 (12.20, 29.35)

0.194

 DBIL, μmol/L

9.1 (5.70, 16.25)

9.3 (6.20, 16.20)

8.75 (5.34, 16.95)

0.267

 CR, μmol/L

106 (81.0, 158.0)

114 (81.0, 158.0)

104 (80.5, 160.0)

0.818

 NT-proBNP, pg/ml

2283 (1146, 5201)

2850 (1270, 6074)

1958 (1104, 4581)

0.092

 cTnT, ng/ml

0.43 (0.21, 0.90)

0.59 (0.24, 1.00)

0.36 (0.19, 0.83)

0.252

LVEF, %

62 (55, 66)

62 (53, 66)

61 (55, 66)

0.924

  1. Continuous data were presented as mean (SD) or median (IQR). Categorical data were presented as counts (%)
  2. NIV noninvasive ventilation, Vt tidal volume, PS pressure support, PEEP positive end expiratory pressure, FiO2 fraction of inspired oxygen, VAS visual analogue scale, NIS NIV intolerance score, RR respiratory rate, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, CVP central venous pressure, Hb hemoglobin, WBC white blood cell, PLT platelet, ALT alanine aminotransferase, AST aspartate transaminase, TBiL total bilirubin, DBiL direct bilirubin, CR creatine, NT-pro BNT N terminal pro B type natriuretic peptide, cTnT cardiac troponin T, LVEF left ventricular ejection fraction